episodic cluster headache research hub

A phase 3 randomized, placebo-controlled, triple blind parallel-group study of candesartan in adults with episodic cluster headache (Episodic CandClus2)

This study is testing a new medicine, candesartan, to see if it can help people who get severe cluster headaches. Researchers want to know if it can reduce how often and how bad these headaches are.